Crohn’s disease is notoriously difficult to manage. Despite the fact that traditional pharmaceuticals and biologic therapies are available, for many sufferers, these options are insufficient for effectively reducing symptoms.
The use of antibiotics is all too common in modern medicine, with risks that are becoming increasingly evident. While they are literally life-saving in many instances, they may also lead to antibiotic-induced colitis in some patients.
A growing body of research into autism and gastrointestinal problems suggests that treatments targeting the gut microbiome may provide significant relief for distressing symptoms and improve quality of life for patients.
In recent years, researchers have been increasingly recognizing the gut-brain axis as a potential target for intervention in a broad range of challenging medical conditions, including neurological, intestinal, and psychiatric disorders.